New Two-Year Data for Evrysdi Will Lead to Increased Competition in SMA Market

Despite EU and Japan approvals, forecast for Gilead and Galapagos’ Jyseleca (filgotinib) in the US less sunny than once hoped

Big Pharma unscathed by Covid-19 crisis as market caps soar in Q2 2020

EU, UK bodies urge medicine prioritisation in Brexit trade talks

The Association of the British Pharmaceutical Industry (ABPI) and European Federation of Pharmaceutical Industries and...

Karnataka, Goa, Tamil Nadu, and Kerala: Mixed success for southern India’s pharma manufacturing industry

PAH patients to benefit amid telemedicine regulatory changes in light of 2020 US election

Monte Rosa Therapeutics raises Series B funds for drug development

Monte Rosa Therapeutics has raised $96m in a Series B funding round to further develop...

Indivior lays out restructuring plans to cut down expenses

UK-based pharmaceutical firm Indivior has stated that it is restructuring the organisational and financial locus...

ESMO 2020: Autolus Therapeutics’ dual-antigen CAR-T agent shows early signs of efficacy

Gerresheimer Group

Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass...